Ginkgo Bioworks Holdings, Inc.
Ginkgo Bioworks Holdings, Inc. (DNA) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
dna · stock forecast · 11 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$12.00
Consensus
$7.84
-4.0% upside
Low
$4.35
Median: $7.5 · Last Close: $8.16
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$7.84
-4.0% upside
High Target
$12
47.0%
Low Target
$4.35
-46.7%
Current Price
$8.16
as of today
Based on analyst price targets, the DNA stock price prediction for the next 12 months ranges from $4.35 to $12. The consensus DNA price forecast of $7.84 implies -4.0% upside from the current price of $8.16.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $8.33 | ↑ 1.97% |
1-day model range: $8.23–$8.42. Peak: $8.42 (+1.97%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $4 | -50.0% |
| 2028 | $3 | -63.7% |
| 2029 | $3 | -69.2% |
| 2030 | $2 | -71.8% |
| 2031 | — | -73.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · DNA · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-03-12 | BTIG | Maintains | Sell→Sell |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-08-25 | BTIG | Maintains | Sell→Sell |
| 2024-09-20 | TD Cowen | Maintains | Buy→Buy |
| 2024-08-23 | BTIG | Maintains | Sell→Sell |
| 2024-07-09 | Goldman Sachs | Maintains | Sell→Sell |
| 2024-06-26 | BTIG | Maintains | Sell→Sell |
| 2024-05-15 | BTIG | Downgrade ↓ | Neutral→Sell |
| 2024-05-15 | Morgan Stanley | Maintains | Equal Weight→Equal Weight |
| 2024-05-10 | William Blair | Downgrade ↓ | Market Perform→Underperform |
Wall Street analysts have recently issued updated ratings on Ginkgo Bioworks Holdings, Inc. (DNA) stock. Of the recent 33 rating actions, 0 were upgrades and 8 were downgrades. 11 analysts currently cover DNA.
Analyst Recommendation Trends
DNA analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 0 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$174M
↑ 32.8% YoY
Revenue Next Year
$123M
↓ 29.2% YoY
EPS This Year
$-5.64
EPS Next Year
$-4.33
↓ 23.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast DNA EPS of $-5.64 for the current fiscal year, based on estimates from 1 analysts. The DNA revenue forecast is $174M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The DNA stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus DNA price target is $7.84 (-4.0% upside), with an analyst consensus of Buy.
The DNA short-term stock prediction for tomorrow is $8.33 (+1.97%). The DNA stock price prediction for 2027 estimates an average of $4. The DNA stock prediction for 2030 projects a range of $2–$3.
Ginkgo Bioworks Holdings, Inc. trades on NYSE under the ticker DNA. The DNA stock outlook for 2027 is broadly positive, supported by a Buy consensus among 45% of covering analysts.
Frequently asked questions
DNA forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month DNA price target is $7.84, with a high forecast of $12.00 and a low of $4.35. The median price target is shown in the chart above when available. This implies -4.0% potential upside from the current price of $8.16.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.